Whoopi Goldberg, the iconic 68-year-old actor and co-host of The View, is making headlines once again for her bold stance on cannabis as a medicinal powerhouse. In a recent interview with Forbes, Goldberg proclaimed cannabis to be “probably the greatest medicine on the planet,” emphasizing its transformative impact on health issues like menstrual cramps, which she herself has used it to alleviate.
Goldberg is set to launch her own cannabis line, named Emma & Clyde, in July, featuring a range of products including edibles and pre-rolls. Named after her late mother and brother, both of whom used cannabis for different reasons, Goldberg’s brand aims to destigmatize and normalize the use of cannabis for medicinal purposes.
In her candid discussion with Forbes, Goldberg highlighted the accessibility and affordability of herbal medicine like cannabis, noting that it grows naturally and requires no additives, thereby keeping costs reasonable for consumers. She expressed her belief that medicine should be accessible to all, without the stigma that has historically surrounded cannabis.
“For people like me, it was always used to stop the [menstrual] cramps – and the side hustle of that is that it was fun, it made you laugh and stuff,” Goldberg shared, underscoring the dual benefits of cannabis for both medical relief and enjoyment.
Goldberg’s advocacy for cannabis is not new; she previously co-founded the brand Whoopi & Maya in 2016, dedicated to cannabis-infused products aimed at relieving menstrual discomfort. Despite its initial success, the brand ceased operations in February 2020.
Beyond her personal experiences, Goldberg has been vocal about broader implications of cannabis use, advocating for its medicinal benefits across various health conditions, including support for pediatric medical marijuana.
While Goldberg’s focus on cannabis as a health solution is well-documented, she recently sparked further debate by discussing her use of the weight-loss drug Mounjaro on The View. Addressing her weight struggles candidly, Goldberg’s openness reflects her ongoing commitment to discussing health issues openly and honestly.
With the launch of Emma & Clyde approaching, Goldberg’s latest venture aims to redefine the conversation around cannabis, positioning it not just as a recreational substance but as a legitimate and beneficial form of medicine.
As Goldberg prepares to bring Emma & Clyde to market on July 20, her advocacy for cannabis continues to resonate, challenging outdated perceptions and promoting a more inclusive approach to health and wellness.
